The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalities-Reference-Cited by-同舟云学术

The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalities

Published:2018-12 Issue: Volume:75 Page:23-28
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Jakovic Ljubomir^ORCID,Bogdanovic Andrija,Djordjevic Vesna,Dencic-Fekete Marija,Kraguljac-Kurtovic Nada,Knezevic Vesna,Tosic Natasa^ORCID,Pavlovic Sonja,Terzic Tatjana

Funder

Ministry of Education, Science and Technological Development of Serbia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Proposals for the classification of the acute leukemias; French-American-British (FAB) co-operative group;Bennett;Br. J. Haematol.,1976

2. Reproducibility of the French-American-British classification of acute leukemia: the Southwest Oncology Group Experience;Head;Am. J. Hematol.,1985

3. Significance of FAB subclassification of “acute myeloid leukemia, NOS “in the 2008 WHO classification: analysis of 5848 newly diagnosed patients;Walter;Blood,2013

4. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Second MIC Cooperative Study Group;Bennett;Br. J. Haematol.,1988

5. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Prediction and Streamline of Nucleophosmin Mutation Status in Acute Myeloid Leukemia Using Cup-Like Nuclear Morphology;Medicina;2024-09-04

2. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy;Clinical and Experimental Medicine;2023-11-04

3. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy.;2023-02-06

4. De novo acute myeloid leukemia harboring concomitant t(8;21)(q22;q22);RUNX1::RUNX1T1 and BCR::ABL1 (p190 minor transcript);Journal of Hematopathology;2022-07-31

5. An End-to-End Pipeline for Early Diagnosis of Acute Promyelocytic Leukemia Based on a Compact CNN Model;Diagnostics;2021-07-11